Realizing the benefits of human genetics and genomics research for people everywhere.
A draft bill introduced in May 2019 sought to reform Section 101 of the U.S. Patent Act. If passed, the legislation would allow for the patenting of genes by effectively overturning the 2013 Association for Molecular Pathology (AMP) vs. Myriad Supreme Court decision. Related: Joint Letter from ASHG and ACMG Leadership to Bill Sponsors (July... Read More
Technology Transfer Associates assist with the licensing and commercialization of patented technology, a function downstream of patent agents, who identify patentable technologies and obtain patents. Those working in technology transfer typically work at universities, hospitals, or other research institutions. They rely on technical expertise as well as business sense to match patented technologies with industry... Read More
Patent Agents assess the patentability of new technologies, processes, and treatments, and help researchers write and obtain patents. These professionals must register with the US Patent and Trademark Office (USPTO) by passing a bar examination. Unlike patent attorneys, patent agents do not need a law degree, but also cannot represent clients in court cases. Patent agents typically... Read More
The Association of Molecular Pathology speaks out against gene patenting. Read More
Head of Human Disease Genetics Novartis Institutes of Biomedical Research ASHG: What are the biggest challenges you encountered when acclimating to the pace and demands of industry? What skills do you wish you had worked on in advance? Dr. Morgan: Working in pharma requires a broad knowledge base and the flexibility to change from one focus to... Read More